Cobalt-based hybrid nanoparticles loaded with curcumin for ligand-enhanced synergistic nanocatalytic therapy/chemotherapy combined with calcium overload

Mengyang Li,Zijie Lu,Chao Fang,Bingzhu Zheng,Yike Fu,Xiang Li
DOI: https://doi.org/10.1039/d4tb00220b
IF: 7.571
2024-03-31
Journal of Materials Chemistry B
Abstract:The therapeutic efficacy of Fenton or Fenton-like nanocatalysts is usually restricted by the inappropriate pH value and limited concentration of hydrogen peroxide (H2O2) in tumor site. Herein, calcium carbonate (CaCO3)-mineralized cobalt silicate hydroxide hollow nanocatalysts (CSO@CaCO3, CC) were synthesized and loaded with curcumin (CCC). This hybrid system can simultaneously realize nanocatalytic therapy, chemotherapy and calcium overload. With the stabilization of liposome, CCC is able to reach tumor site smoothly. The CaCO3 shell firstly degrades in acidic tumor environment, releasing Cur and Ca2+, and the pH value of tumor is increased simultaneously. Then the exposed CSO catalyzes Fenton-like reaction to transfer H2O2 into ·OH, and enhance the cytotoxicity of curcumin (Cur) via catalytic oxidizing it to ·Cur radical. Curcumin not only induces chemotherapy effect, but also serves as nucleophilic ligand and electron donor in the catalytic system, enhancing the Fenton-like activity of CCC by electron transfer. In addition, calcium overload also amplifies the efficacy of ROS-based therapy. In vitro and in vivo results shows that CCC exhibited excellent synergistic tumor inhibition effect without any clear side effect. This work proposed a novel concept of nanocatalytic therapy/chemotherapy synergistic mechanism by the ligand-induced enhancement of Fenton-like catalytic activity, and inspired the construction of combined therapeutic nanoplatforms and multifunctional nanocarriers for drug and ion delivery in the future.
materials science, biomaterials
What problem does this paper attempt to address?